Anti-SIAT6/ ST3GAL3/ EIEE15 functional antibody

Anti-SIAT6/ ST3GAL3/ EIEE15 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to ST3GAL3/ST3GAL3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0488-Ab-1/ GM-Tg-hg-SE0488-Ab-2Anti-Human ST3GAL3 monoclonal antibodyHuman
GM-Tg-rg-SE0488-Ab-1/ GM-Tg-rg-SE0488-Ab-2Anti-Rat ST3GAL3 monoclonal antibodyRat
GM-Tg-mg-SE0488-Ab-1/ GM-Tg-mg-SE0488-Ab-2Anti-Mouse ST3GAL3 monoclonal antibodyMouse
GM-Tg-cynog-SE0488-Ab-1/ GM-Tg-cynog-SE0488-Ab-2Anti-Cynomolgus/ Rhesus macaque ST3GAL3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0488-Ab-1/ GM-Tg-felg-SE0488-Ab-2Anti-Feline ST3GAL3 monoclonal antibodyFeline
GM-Tg-cang-SE0488-Ab-1/ GM-Tg-cang-SE0488-Ab-2Anti-Canine ST3GAL3 monoclonal antibodyCanine
GM-Tg-bovg-SE0488-Ab-1/ GM-Tg-bovg-SE0488-Ab-2Anti-Bovine ST3GAL3 monoclonal antibodyBovine
GM-Tg-equg-SE0488-Ab-1/ GM-Tg-equg-SE0488-Ab-2Anti-Equine ST3GAL3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0488-Ab-1/ GM-Tg-hg-SE0488-Ab-2; GM-Tg-rg-SE0488-Ab-1/ GM-Tg-rg-SE0488-Ab-2;
GM-Tg-mg-SE0488-Ab-1/ GM-Tg-mg-SE0488-Ab-2; GM-Tg-cynog-SE0488-Ab-1/ GM-Tg-cynog-SE0488-Ab-2;
GM-Tg-felg-SE0488-Ab-1/ GM-Tg-felg-SE0488-Ab-2; GM-Tg-cang-SE0488-Ab-1/ GM-Tg-cang-SE0488-Ab-2;
GM-Tg-bovg-SE0488-Ab-1/ GM-Tg-bovg-SE0488-Ab-2; GM-Tg-equg-SE0488-Ab-1/ GM-Tg-equg-SE0488-Ab-2
Products NameAnti-ST3GAL3 monoclonal antibody
Formatmab
Target NameST3GAL3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ST3GAL3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0488-Ag-1Recombinant multi-species SIAT6/ ST3GAL3/ EIEE15 protein


    Target information

    Target IDGM-SE0488
    Target NameST3GAL3
    Gene ID6487,20441,64445,703599,610736,101081911,444859,100053104
    Gene Symbol and SynonymsDEE15,EIEE15,MRT12,Siat3,SIAT6,ST3Gal III,ST3GAL3,ST3GALII,ST3GalIII,ST3N
    Uniprot AccessionQ11203,Q02734
    Uniprot Entry NameSIAT6_HUMAN,SIAT6_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000126091
    Target ClassificationN/A

    The target: ST3GAL3, gene name: ST3GAL3, also named as EIEE15, MRT12, SIAT6, ST3GALII, ST3Gal III, ST3GalIII, ST3N. The protein encoded by this gene is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The encoded protein is normally found in the Golgi apparatus but can be proteolytically processed to a soluble form. This protein is a member of glycosyltransferase family 29. Mutations in this gene have been associated with a form of autosomal recessive nonsymdromic cognitive disability as well as infantile epileptic encephalopathy. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.